Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: Patients with neurofibromatosis type 2 (NF2) are an important subgroup of patients undergoing peripheral nerve schwannoma excision, however data on their outcomes are lacking. Co-existing peripheral neuropathy can complicate the clinical presentation and recovery in NF2. We designed a study to compare outcomes of peripheral nerve schwannoma excision in NF2 patients with excision of isolated, sporadic schwannomas in non-NF2 patients. METHODS: 30 peripheral nerve schwannoma excisions from 15 NF2 patients were compared to 30 excised isolated schwannomas. These were matched for age, size, nerve and level of involvement. Final outcomes were scored on a scale of 0 (no improvement) to 3 (complete symptom resolution). Data were analysed by McNemars test and Wilcoxen matched pairs test. RESULTS: NF2 patients had multiple lesions and more pre-operative weakness (p = 0.041) and sensory loss (p = 0.133) compared to controls. Post-operative neurological morbidity occurred in both groups after schwannoma excision. Final outcome scores of 2.4 in NF2 and 2.2 in controls indicate great improvement or complete resolution in the majority. CONCLUSIONS: Outcomes in the NF2 group are not different to controls, despite NF2 patients having more significant pre-operative deficit and co-existing neuropathology. These findings suggest that surgical intervention should be offered to NF2 patients with peripheral nerve schwannomas.

Original publication

DOI

10.1016/j.bjps.2015.05.026

Type

Journal

J Plast Reconstr Aesthet Surg

Publication Date

09/2015

Volume

68

Pages

1199 - 1203

Keywords

Peripheral nerve sheath tumour, Peripheral nerve surgery, Schwannoma, Type 2 neurofibromatosis, Adult, Case-Control Studies, Confidence Intervals, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neurilemmoma, Neurofibromatosis 2, Neurosurgical Procedures, Peripheral Nervous System Neoplasms, Reference Values, Retrospective Studies, Risk Assessment, Treatment Outcome, United Kingdom